Nuntius Therapeutics
Private Company
Genetic medicines to cure patients with life-threatening diseases
Biotechnology Research
London
2-10 employees
Founded 2021
About Nuntius Therapeutics
We develop transformative mRNA therapies by leveraging our ground-breaking proprietary delivery technology, machine learning and superior nucleic acid engineering.
Funding
Total Funding
$125.0K
No. of Funding Rounds
1
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos